Partner
Registered Patent Attorney
Heather employs a strategic and focused approach to help innovative life science clients execute transactions and protect their IP assets. Clients trust Heather's counsel on tough patent strategic issues and rely on her deep scientific knowledge and background in biological and biomedical sciences.
Heather counsels life sciences clients on a variety of intellectual property matters. She excels at due diligence studies, loss of exclusivity analyses, and agreement drafting in connection with buy- and sell-side transactions and collaborations for her clients, which range from preclinical biotechnology companies to large clinical pharmaceutical companies. Heather regularly advises on Hatch-Waxman issues, biosimilars strategy, and litigation and post-grant proceedings, such as inter partes reviews. She also manages the worldwide prosecution of numerous life sciences patent portfolios.
Heather has extensive experience counseling clients in intellectual property matters in areas including gene editing, immunotherapies, regenerative medicine, rare diseases, pharmaceutical formulations, genetically modified plants and seeds, enzyme and other large-molecule technology, and small-molecule chemistry. She routinely works with the firm's corporate team to counsel international corporations in preparing their intellectual property portfolios for U.S. cross-border securities transactions.
Heather is a registered patent attorney with the U.S. Patent and Trademark Office. In addition to earning her J.D., Heather has a Ph.D. in biological and biomedical sciences and a bachelor's degree in biology.
Heather has served as lead IP counsel for the following:
Heather has conducted due diligence and transaction drafting for the following:
Heather's critical IP strategy and litigation experience includes the following:
Representative matters may include engagements before joining Troutman Pepper.
Sponsored Events
04.16.24
2024 Bloom Burton & Co. Healthcare Investor Conference
Sponsored Events
03.22.24
New York Intellectual Property Law Association's (NYIPLA) 102nd Annual Dinner in Honor of the Federal Judiciary
Articles + Publications
02.28.24
USPTO's Guidance on Inventorship of AI-Assisted Inventions Remains True to Fundamental Principles, But May Not Be the Right Test
Sponsored Events
04.25.23
2023 Bloom Burton & Co. Healthcare Investor Conference
Articles + Publications
01.25.23
After JPM, What Are the Legal Dealmaking Trends to Watch?
Firm News
09.02.21
Troutman Pepper Health Sciences IP Partners Recognized in IAM Strategy 300